Receptor binding specificities of Herstatin and its intron 8-encoded domain.

FEBS Lett

Oregon Health & Science University, Department of Biochemistry and Molecular Biology, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

Published: June 2004

Retention of intron 8 in alternative HER-2 mRNA generates an inhibitory secreted ligand, Herstatin, with a novel receptor-binding domain (RBD) encoded by the intron. This study examines binding interactions with several receptors and investigates sequence variations in intron 8. The RBD, expressed as a peptide, binds at nM concentrations to HER-2, the EGFR, DeltaEGFR, HER-4 and to the IGF-1 receptor, but not to HER-3 nor to the FGF-3 receptor, whereas a rare mutation in the RBD (Arg to Ile) eliminates receptor binding. The full-length Herstatin binds with 3-4-fold higher affinity than its RBD, but with approximately 10-fold lower affinity to the IGF-IR. Sequence conservation in rhesus monkey but not in rat suggests that intron 8 recently diverged as a receptor-binding module critical for the function of Herstatin.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2004.05.027DOI Listing

Publication Analysis

Top Keywords

receptor binding
8
intron
5
receptor
4
binding specificities
4
herstatin
4
specificities herstatin
4
herstatin intron
4
intron 8-encoded
4
8-encoded domain
4
domain retention
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!